← Back to Analyst Consensus 
PAVM Buy
PAVmed Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 27, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Jun 8, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Apr 9, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 10, 2025 | Ascendiant Capital | maintain | Buy → Buy | $17 | 38% |
| Oct 6, 2025 | Ascendiant Capital | maintain | Buy → Buy | $20 | 38% |
| Jun 6, 2025 | Ascendiant Capital | maintain | Buy → Buy | $19 | 38% |
| Apr 21, 2025 | Ascendiant Capital | maintain | Buy → Buy | $19.5 | 38% |
| Dec 9, 2024 | Ascendiant Capital | maintain | Buy → Buy | $19 | 38% |
Price Target Trend
Apr 3, 2026 Oct 26, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days